Optiscan Imaging Limited
OIL.ASXHealth Care
Optiscan Imaging Ltd (ASX:OIL) is a global medical technology company developing real-time digital pathology and precision surgery hardware and software solutions based on miniaturised endomicroscopy for live, single-cell resolution imaging.
Market Data
$0.125
+0.1%$122.7M
-100000.0x
$-0.008
0.00%
+0.1%
Latest Earnings
Appendix 4D
25 February 2026
Optiscan Imaging reported a challenging H1FY26 with revenue declining 43% to $339k due to restricted research funding affecting ViewnVivo sales in USA and China. The company raised $17.8M in capital to fund clinical studies and regulatory submissions, strengthening its balance sheet with net assets increasing to $22.0M. Despite increased R&D investment of $2.7M to accelerate technology development, the net loss widened 43% to $3.4M. Key points: Successfully raised $17.8M through fully underwritten pro-rata entitlement offer; Net assets increased significantly to $22.0M from $7.7M, strengthening balance sheet; Strong working capital position with $21.5M excess of current assets over liabilities
Recent Announcements
Appendix 4D
Optiscan Imaging reported a challenging H1FY26 with revenue declining 43% to $339k due to restricted research funding affecting ViewnVivo sales in USA and China. The company raised $17.8M in capital to fund clinical studies and regulatory submissions, strengthening its balance sheet with net assets increasing to $22.0M. Despite increased R&D investment of $2.7M to accelerate technology development, the net loss widened 43% to $3.4M. Key points: Successfully raised $17.8M through fully underwritten pro-rata entitlement offer; Net assets increased significantly to $22.0M from $7.7M, strengthening balance sheet; Strong working capital position with $21.5M excess of current assets over liabilities
Get real-time alerts for OIL
Receive AI-powered earnings summaries and instant notifications when Optiscan Imaging Limited releases results.
Register Free